ArticleCell discovery2022

A broader neutralizing antibody against all the current VOCs and VOIs targets unique epitope of SARS-CoV-2 RBD.

Shuo Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.